Brent Binkowski
CIK 1644355 · CHIEF OPERATING OFFICER · last filed 2026-08-13
Brent Binkowski is a CHIEF OPERATING OFFICER who has filed 7 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider sold $3.3K of CVRX on Aug 13, 2026. Across all open-market trades the lifetime net is +$73.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $43.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CVRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MINNEAPOLIS, MN 55369
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVRX | CHIEF OPERATING OFFICER | 30,291 | $1.42 | $43.0K | $73.1K | 4 | 2026-08-13 |
| VASCULAR SOLUTIONS INC (VASC) Delisted | Sr. VP of Operations | 8,680 | — | — | $0 | 2 | 2016-01-26 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-13 | CVRX | Sell (S) | −1,309 | -$3.3K | EDGAR |
| 2026-08-13 | CVRX | Buy (P) | +26,223 | $76.4K | EDGAR |
| 2026-03-03 | CVRX | Grant (A) | +15,000 | $0 | EDGAR |
| 2025-08-13 | CVRX | Grant (A) | +16,600 | $0 | EDGAR |
| 2017-02-22 | — | Disp (D) | −8,680 | $0 | |
| 2016-01-26 | VASCULAR SOLUTIONS INC (VASC) Delisted | Grant (A) | +1,985 | $0 | EDGAR |
| 2015-07-27 | VASCULAR SOLUTIONS INC (VASC) Delisted | Grant (A) | +6,695 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.